Isla, Dolores; Zugazagoitia, Jon; Arriola, Edurne; García-Campelo, Rosario; Marti-Blanco, Cristina; Diz-Tain, María-Pilar; López-Brea, Marta; Moreno-Vega, Alberto-Luis; León-Mateos, Luis; Oramas, Juana; Gutiérrez-Calderón, Vanesa; Majem, Margarita; Sánchez-Hernández, Alfredo; Aguado, Carlos; Álvarez-Cabellos, Ruth; Massuti, Bartomeu; Moreno, Amaia; Firvida-Pérez, José-Luis; Valdivia, Javier; González-Cordero, Marta; Zafra-Poves, Marta; Domine, Manuel; García-Navalon, Francisco-Javier; Villanueva, Noemi; Provencio, Mariano; Juan-Vidal, Oscar; Rivas-Corredor, Carlos; Olmedo-García, María-Eugenia; Palmero, Ramón; López-Castro, Rafael; Carcereny, Enric; Lechuga, José-Luis; Domínguez, Marta; Callejo, Ángel; Paz-Ares, Luis
(ELSEVIER IRELAND LTD, 2025-11)
BACKGROUND: Immunotherapy trials involving patients with extensive-stage small cell lung cancer (ES-SCLC) from real-world clinical practice are needed. We aimed to evaluate the safety and effectiveness of durvalumab plus ...